Two and a half million people have already been immunized and seven million doses of the covid vaccine have been administered in Spain.
With these figures, the President of the Spanish Government, Pedro Sánchez, has assured people in a tweet that Spain is meeting its objectives.
In the second quarter of the year, the campaign is expected to advance at a faster pace, with the goal of having 70% of people vaccinated by summer still a real possibility Although at the moment vaccination is progressing slowly in Spain, the Government is optimistic.
Pedro Sánchez has been talking about meeting objectives, with more than seven million doses administered, that is, 83% of those received. There are already two and a half million Spaniards fully immunized.
Sánchez stated in a Tweet: We continue to meet the objectives set. More than 7 million doses administered and 2.5 million people immunized in the 3 months since we started the vaccination process against #COVID19 in Spain.
Spain hopes to have all those over 80 vaccinated in the next two weeks.
For this, it is essential that the pharmaceutical companies comply with the shipping dates. The department of Health are stating that vaccinations will increase fourfold by the end of April when the arrival of new doses is expected to increase.
Among them is the Janssen vaccine. It is the only vaccine that needs a single dose to immunize and clinical trials have already begun in Spain with children between 12 and 17 years old.
The President of Janssen Says 70% Vaccination Can Be Done
Luis Díaz Rubio, president in Spain and Portugal of Janssen – one of the pharmaceutical manufacturers of vaccines against covid-19 – has said that, with the extension of vaccination, in a few months we will have a situation “very different from what we have now “. Díaz Rubio, who has participated in a round table of the Future Europe Cycle, organized by El País, has stated that he is optimistic about vaccination, for which the first doses from the pharmaceutical company Jansen will arrive in April.
In addition, he pointed out that the expectations of having a significant percentage of the population vaccinated throughout the summer “can be met and will be met”, and he has predicted that in the coming months there will be an exponential curve in the number of immunizations. He stated that Janssen will join the group of pharmaceutical companies that are supplying vaccines in Spain in the coming weeks and that in a few months “we will have a very different situation to the one we have now.”
